Literature DB >> 15188366

Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.

Arne Hansen1, Mirko Gosemann, Axel Pruss, Karin Reiter, Sarka Ruzickova, Peter E Lipsky, Thomas Dörner.   

Abstract

OBJECTIVE: To delineate disturbances in peripheral B cell memory in primary Sjögren's syndrome (SS).
METHODS: Isotype-specific immunoglobulin (Ig) heavy-chain transcripts were analyzed in single-sorted CD19+,CD27- naive and CD19+,CD27+ memory B cells from patients with primary SS and normal healthy control subjects.
RESULTS: A significantly higher frequency of B cells expressing mu-, alpha-, and/or gamma-chain transcripts were found in patients with primary SS compared with controls (58.0% versus 14.3%; P < 0.0001). Notably, 30.5% of individual B cells (for primary SS, 38.7%; for controls, 12.7% [P < 0.0001]) simultaneously expressed transcripts for different Ig heavy-chain isotypes using identical V(H)-D-J(H) rearrangements. However, these cells lacked surface expression of more than one of the respective Ig heavy-chain isotypes as well as messenger RNA (mRNA) transcripts for 2 germinal center markers, activation-induced cytidine deaminase, and Bcl-6. In contrast with the findings in normal healthy controls, peripheral B cell memory in patients with primary SS was characterized by 1) circulating CD27+ B cells expressing heavily mutated Ig V(H) transcripts (mutational frequency 8.6% versus 4.3%; P < 0.0001), 2) significantly enhanced mutational frequencies of C mu transcripts (9.6% versus 2.5%; P < 0.0001), 3) a high proportion (61.2%) of CD27+ B cells expressing transcripts for multiple Ig heavy-chain isotypes, and 4) a CD27- memory-type B cell subpopulation expressing mutated C mu transcripts.
CONCLUSION: Altogether, both B cell hyperactivity and striking abnormalities in peripheral B cell memory are indicated at the single-cell mRNA level in patients with primary SS. Detection of multiple Ig heavy-chain transcripts in peripheral CD19+,CD27+ memory B cells of patients with SS may represent the abnormal retention of pre-switch mRNA transcripts in circulating post-switch B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188366     DOI: 10.1002/art.20276

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

Review 1.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

3.  Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.

Authors:  Mustimbo E P Roberts; Denise Kaminski; Scott A Jenks; Craig Maguire; Kathryn Ching; Peter D Burbelo; Michael J Iadarola; Alexander Rosenberg; Andreea Coca; Jennifer Anolik; Iñaki Sanz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

4.  Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters.

Authors:  T N Lavoie; C M Stewart; K M Berg; Y Li; C Q Nguyen
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

5.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

Review 6.  B-cell depletion and repopulation in autoimmune diseases.

Authors:  Jacques-Olivier Pers; Capucine Daridon; Boutahar Bendaoud; Valérie Devauchelle; Christian Berthou; Alain Saraux; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

7.  Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.

Authors:  E William St Clair; Marc C Levesque; Eline T Luning Prak; Frederick B Vivino; Chacko J Alappatt; Meagan E Spychala; Josiah Wedgwood; James McNamara; Kathy L Moser Sivils; Lytia Fisher; Philip Cohen
Journal:  Arthritis Rheum       Date:  2013-04

8.  Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis.

Authors:  X Xu; H-C Hsu; J Chen; W E Grizzle; W W Chatham; C R Stockard; Q Wu; P A Yang; V M Holers; J D Mountz
Journal:  Scand J Immunol       Date:  2009-09       Impact factor: 3.487

9.  Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.

Authors:  L A Aqrawi; M Ivanchenko; A Björk; J I Ramírez Sepúlveda; J Imgenberg-Kreuz; M Kvarnström; P Haselmayer; J L Jensen; G Nordmark; K Chemin; K Skarstein; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

10.  Targeted therapies in rheumatoid arthritis: Focus on rituximab.

Authors:  Y K Teng; T W Huizinga; J M van Laar
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.